MONTREAL, QUEBEC -- (MARKET WIRE) -- November 24, 2006 -- Mistral Pharma Inc. (TSX VENTURE: MIP)(the “Corporation”, “Mistral”) announces today its financial results and review of operating highlights for the quarter ended September 30, 2006. “We are pursuing the development of our products and our good financial position allows us to envision new projects” said Mr. Bertrand Bolduc, the Corporation’s President & CEO.
